Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to GLP-1 receptor agonist treatment

BACKGROUND: Glucagon-like Peptide-1 receptor agonists (GLP-1 RA) and metabolic and bariatric surgery (MBS) both improve cardiovascular outcomes in patients with severe obesity and type-2 diabetes (T2D). The aim of the present study was to assess the impact of MBS on major cardiovascular adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenberg, Erik, Näslund, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113141/
https://www.ncbi.nlm.nih.gov/pubmed/36670155
http://dx.doi.org/10.1038/s41366-023-01254-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113141/
https://www.ncbi.nlm.nih.gov/pubmed/36670155
http://dx.doi.org/10.1038/s41366-023-01254-z

Ejemplares similares